You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Special Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Genetic Disorders
 •Ophthalmological Disorders, Other
 •Alert me on articles by topic

Genetic Testing for Inherited Eye Disease

Edwin M. Stone, MD, PhD

Arch Ophthalmol. 2007;125(2):205-212.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The data, devices, and molecular techniques that have become part of the practice of medicine as a result of the Human Genome Project are for most clinicians both inspiring and intimidating. While the potential for tests that can help make very accurate diagnoses of rare genetic diseases and that can identify genetic predispositions to more common ones is exciting, the translation of this concept to practice has been slower and more complicated than most people would have imagined.

The reasons for the slow translation of genomic discoveries from the laboratory to the clinic range from the vagaries of intellectual property law to the different strategies that various countries have chosen to pay for the medical care of their citizens. However, our understanding of the genes involved in inherited eye disease is now sufficiently advanced and molecular technology is sufficiently powerful that we can reasonably expect . . . [Full Text of this Article]

INDICATIONS FOR GENETIC TESTING

WHAT IS A GENETIC TEST?

CLINICALLY USEFUL TESTS

NORMAL GENETIC VARIATION

THE MUTATION DETECTION PROBABILITY DISTRIBUTION

THE VALUE OF CLINICAL HYPOTHESES

THE VALUE OF A MULTIPLATFORM APPROACH

MEANINGFUL WRITTEN REPORTS

CONCLUSION

AUTHOR INFORMATION

Author Affiliation: The Carver Family Center for Macular Degeneration, The Howard Hughes Medical Institute, The University of Iowa Carver College of Medicine, Iowa City.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Divergent Phenotypes of Vision and Accessory Visual Function in Mice with Visual Cycle Dysfunction (Rpe65rd12) or Retinal Degeneration (rd/rd)
Thompson et al.
IOVS 2008;49:2737-2742.
ABSTRACT | FULL TEXT  

Genomic Promise: Personalized Medicine for Ophthalmology
Wiggs
Arch Ophthalmol 2008;126:422-423.
FULL TEXT  

Genetic Ophthalmology and the Era of Clinical Care
Sieving and Collins
JAMA 2007;297:733-736.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.